Form 4 Filing for Eli Lilly & Co. Insider Transaction

Gabrielle Sulzberger, a director at Eli Lilly & Co. (LLY), acquired 4.3232 shares of common stock on July 20, 2026, at a price of $1146.9 per share. These shares were acquired in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares following her separation from service. The transaction was reported on July 21, 2026. Following this transaction, Sulzberger directly owns 2999.7188 shares of Eli Lilly common stock.